Vanderbilt Hemostasis-Thrombosis Clinic — Nashville, Tennessee

Vanderbilt Hemostasis-Thrombosis Clinic is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Vanderbilt Hemostasis-Thrombosis Clinic has participated in 7 clinical trials.

Therapeutic areas: Hemophilia B, Congenital Bleeding Disorder, Haemophilia A.

Sponsors: Ultragenyx Pharmaceutical Inc, Novo Nordisk A/S, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Hemostasis-Thrombosis Clinic?

Vanderbilt Hemostasis-Thrombosis Clinic has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Hemostasis-Thrombosis Clinic conducted?

Vanderbilt Hemostasis-Thrombosis Clinic has 7 clinical trials on record. Their work covers Hemophilia B, Congenital Bleeding Disorder, Haemophilia A.

Is Vanderbilt Hemostasis-Thrombosis Clinic accredited by Crixeo Clinical Trials?

Vanderbilt Hemostasis-Thrombosis Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Hemostasis-Thrombosis Clinic?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.